Bisphosphonate-associated osteonecrosis of the jaw - Patient care considerations: Overview for the orthopaedic nursing healthcare professional

Orthopaedic Nursing

Volumn 29, Issue 3, 2010, Pages 176-180

  Cohen, Harold V ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

BONE NECROSIS; BONE REMODELING; CHEMICALLY INDUCED DISORDER; CONTINUING EDUCATION; HUMAN; JAW DISEASE; NURSING; REVIEW;

BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; DIPHOSPHONATES; EDUCATION, CONTINUING; HUMANS; JAW DISEASES; OSTEONECROSIS;

EID: 77953113349     PISSN: 07446020     EISSN: 1542538X     Source Type: Journal    
DOI: 10.1097/NOR.0b013e3181dcd2a2     Document Type: Review

References (9)

1. Almazroos, S., & Sook-Bin, W. (2009). Bisphosphonate and non-bisphosphonate associated osteonecrosis of the jaw-A review. Journal of American Dental Association, 140, 864-875.
2. American Association of Oral and Maxillofacial Surgeons. (2009). Position paper on Bisphosphonate-Related Osteonecrosis of the Jaw-2009 Update. Retrieved from www.aaoms.org
3. Bilezikian, J. (2006). Osteonecrosis of the jaw-Do bisphosphonates pose a risk? New England Journal of Medicine, 355(22), 2278-2281.
4. Coleman, R., Guise, T., Lipton, A., & Roodman, G. (2008). Advances in treating metastatic bone cancer. CME Program, sponsored by InforMEDical Communications. Retrieved from www.informedicalcme.com
5. Edwards, B., Hellstein, J., Jacobsen, P., Kaltman, S., Mariotti, A., & Miglrioratti, C. (2008, December). Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy-Advisory Statement from the American Dental Association Council on Scientific Affairs. Journal of American Dental Association, 139, 1674-1677.
6. American Dental Association-Edwards, B., Hellstein, J., Jacobsen, P., Kaltman, S., Mariotti, A., Miglrioratti, C., (2006). Dental Management of Patients Receiving Oral Bisphosphonate Therapy-Expert Panel Recommendations, Journal of the American Dental Association, 137(8), 1144-1150.
7. Hemphill, R. (2009). Hypercalcemia. eMedicine Specialties- Emergency Medicine- Endocrine & Metabolic. Retrieved from http://emedicine.medscape. com/article/ 766373-overview
8. Kearns, A., Khosla, S., & Kotenuik, P. (2008). Receptor activator of nuclear factor- B ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocrine Reviews, 29(2), 155-192.
9. Smith, M. (2003). Antitumor activity of bisphosphonates. Clinical Cancer Research, 9, 5433-15414